Natera Inc

General ticker "NTRA" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $15.8B (TTM average)

Natera Inc follows the US Stock Market performance with the rate: 71.4%.

Estimated limits based on current volatility of 5.6%: low 129.37$, high 144.72$

Factors to consider:

  • US accounted for 97.7% of revenue in the fiscal year ended 2024-12-31
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [84.59$, 179.17$]
  • 2025-12-31 to 2026-12-31 estimated range: [52.92$, 121.87$]

Financial Metrics affecting the NTRA estimates:

  • Negative: Non-GAAP EPS, $ of -1.53 <= 0.04
  • Negative: negative Operating income
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of 0.65 <= 1.81
  • Positive: Interest expense per share, $ of 0 <= 0
  • Positive: Inventory ratio change, % of -0.73 <= 0
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term NTRA quotes

2025-02-272025-02-282025-03-032025-03-042025-03-052025-03-062025-03-072025-03-102025-03-112025-03-122025-03-132025-03-142025-03-172025-03-182025-03-192025-03-202025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-09125130135140145150155160165
Price $

Long-term NTRA plot with estimates

406080100120140160180Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−1−0.50
NTRAS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $820.22MM $1,082.57MM $1,696.91MM
Operating Expenses $1,361.26MM $1,528.82MM $1,919.20MM
Operating Income $-541.04MM $-446.25MM $-222.29MM
Non-Operating Income $-5.78MM $11.71MM $32.56MM
Interest Expense $9.32MM $12.64MM $0.00MM
R&D Expense $316.42MM $320.68MM $404.14MM
Income(Loss) $-546.82MM $-434.53MM $-189.73MM
Taxes $0.98MM $0.27MM $0.69MM
Profit(Loss)* $-547.80MM $-434.80MM $-190.43MM
Stockholders Equity $705.74MM $765.33MM $1,195.42MM
Inventory $35.41MM $40.76MM $44.74MM
Assets $1,394.47MM $1,441.70MM $1,660.73MM
Operating Cash Flow $-431.50MM $-246.96MM $135.66MM
Capital expenditure $47.70MM $39.20MM $66.42MM
Investing Cash Flow $330.34MM $168.50MM $137.62MM
Financing Cash Flow $482.64MM $254.46MM $30.20MM
Earnings Per Share** $-5.57 $-3.78 $-1.53

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.